JNJ

Auris acquisition could prompt more mega VC rounds
Auris acquisition could prompt more mega VC rounds
EP Vantage
venture capital
JNJ
Auris Health
devices
Flag link:
Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'
Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'
CNBC
JNJ
Apple
Apple Watch
heart arrhythmias
devices
Flag link:
Bayer stresses drug's tolerability in bid for prostate cancer market
Bayer stresses drug's tolerability in bid for prostate cancer market
Yahoo/Reuters
Bayer
prostate cancer
darolutamide
Pfizer
JNJ
Flag link:
Did Johnson & Johnson Just Spit in Alphabet's Face?
Did Johnson & Johnson Just Spit in Alphabet's Face?
Motley Fool
JNJ
Alphabet
Auris Health
robotic surgery
M&A
Verb Surgical
Flag link:
J&J to enter the robotic surgery market with $3.4B Auris Health buy
J&J to enter the robotic surgery market with $3.4B Auris Health buy
Mass Device
JNJ
robotic surgery
Ethicon
M&A
Auris Health
Flag link:
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
Endpoints
JNJ
FDA
advisory panels
esketamine
major depression
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
Flag link:
Approving J&J's new depression drug would be an unusual move for the FDA
Approving J&J's new depression drug would be an unusual move for the FDA
BioPharma Dive
JNJ
esketamine
FDA
advisory panels
Flag link:
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
BioSpace
JNJ
FDA
esketamine
major depression
Flag link:
Johnson & Johnson to be first drug maker to list prices in TV commercials
Johnson & Johnson to be first drug maker to list prices in TV commercials
Stat
JNJ
drug pricing
television ads
Flag link:
Powerful Senate committee invites pharma executives to testify
Powerful Senate committee invites pharma executives to testify
Reuters
Senate
drug pricing
AbbVie
AstraZeneca
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Sanofi
Flag link:
J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits: lawyer
J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits: lawyer
Yahoo/Reuters
JNJ
DePuy
Pinnacle Hip
hip implants
metal-on-metal hip implants
Flag link:
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
earnings
Pfizer
Amgen
AbbVie
JNJ
Merck
Novo Nordisk
Takeda
Flag link:
Philly jury hits J&J’s Ethicon with $41m judgment in pelvic mesh case
Philly jury hits J&J’s Ethicon with $41m judgment in pelvic mesh case
Mass Device
JNJ
Ethicon
pelvic mesh
devices
Flag link:
J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon
J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon
Endpoints
JNJ
MeiraGTx
gene therapy
Flag link:
FDA approves J&J’s Tremfya self-injection pen for psoriasis
FDA approves J&J’s Tremfya self-injection pen for psoriasis
Drug Delivery Business News
JNJ
FDA
Tremfya
psoriasis
Flag link:
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
JNJ
Erleada
prostate cancer
metastatic prostate cancer
Flag link:
3 Big Pharmas Expecting a Softer 2019
3 Big Pharmas Expecting a Softer 2019
Motley Fool
JNJ
AbbVie
Pfizer
Flag link:
Intuitive Surgical Clobbered On Mounting Expenses As J&J, Medtronic Loom
Intuitive Surgical Clobbered On Mounting Expenses As J&J, Medtronic Loom
Investors Business Daily
devices
robotic surgery
Intuitive Surgical
Medtronic
JNJ
Flag link:
Amid controversies, J&J voted most admired pharma
Amid controversies, J&J voted most admired pharma
Biopharma Dive
JNJ
Flag link:

Pages